We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biotechnology Firms Lobby SEC for Sarbanes-Oxley Exemptions
Biotechnology Firms Lobby SEC for Sarbanes-Oxley Exemptions
March 14, 2006
The biotechnology sector is making a final push to ensure the SEC adopts recommendations to exempt smaller companies from financial reporting and auditing requirements, alleging these standards create burdens that will stunt innovation.